Tonix Pharmaceuticals Holding (TNXP) Price to FCF (2014 - 2026)

Tonix Pharmaceuticals Holding has reported Price to FCF for 13 years, with the latest figure at 5.25 in Q2 2026.

• On a quarterly basis, Price to FCF rose 70.28% year-over-year to 5.25 in Q2 2026; TTM through Jun 2026 was 1.36, a 67.36% increase from a year earlier, with the FY2025 full-year figure at 1.29, down 223.59% from the prior year.
• Price to FCF was 5.25 for Q2 2026 at Tonix Pharmaceuticals Holding, down from 4.24 in the prior quarter.
• The five-year high for Price to FCF was 0.29 in Q2 2024, with the low at 17.68 in Q2 2025.
• Average Price to FCF over 5 years is 3.13, with a median of 1.01 recorded in 2022.
• The sharpest annual moves came in 2022 and 2025: Price to FCF soared 99.55% in 2022, then slumped 6031.54% in 2025.
• Over 5 years, Price to FCF stood at 0.52 in 2022, then surged by 42.1% to 0.3 in 2023, then tumbled by 454.94% to 1.66 in 2024, then plunged by 92.81% to 3.2 in 2025, then plunged by 64.11% to 5.25 in 2026.
• The last three Price to FCF figures came in at 5.25 (Q2 2026), 4.24 (Q1 2026), and 3.2 (Q4 2025), per Business Quant data.